The FDA approved Idacio as a biosimilar to Humira, a TNF inhibitor with indications for rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn ...

Adalimumab, sold under its brand name Humira (AbbVie), earned more than $200 billion since it was first approved by the FDA two decades ago. For the last decade, one prescription drug product has ...

Among patients with psoriatic arthritis (PsA), treatment with upadacitinib (Rinvoq) led to greater improvements from baseline in Routine Assessment of Patient Index Data 3 (RAPID3) scores compared ...

Simlandi injection, an interchangeable biosimilar to Humira, is now available in the U.S. for the treatment of psoriatic arthritis, plaque psoriasis and other conditions, Teva Pharmaceuticals and ...

Humira is also approved for certain children with these conditions. ... Psoriatic arthritis. Amjevita is prescribed to treat active psoriatic arthritis in adults. With this condition, ...

Celltrion USA is offering an 80 mg dose of Yuflyma (adalimumab-aaty), a high-concentration (100mg/ml) and citrate-free formulation of Humira (adalimumab) biosimilar, in the United States.

There are more than 100 types of arthritis, and they typically cause joint pain and stiffness. While there is no cure for arthritis, you can take steps to manage the condition. The specific ...

People with psoriatic arthritis often have psoriasis. They tend to have or get a few other diseases, too. There's no clear reason why these other conditions go hand in hand, and researchers are ...

Enthesitis is a key, but often overlooked, feature of psoriatic arthritis. Learn how this inflammation at tendon and ligament attachment sites can affect diagnosis, symptoms, and treatment.